Biomaterial-based technologies for brain anti-cancer therapeutics and imaging
Authors:
- G. OriveGOG. Orive
- O.A. AliOAO.A. Ali
- E. AnituaEAE. Anitua
- J.L. PedrazJPJ.L. Pedraz
- D.F. EmerichDED.F. Emerich
- 1 August 2010
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1806 (1) , 96-107
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Engulfing tumors with synthetic extracellular matrices for cancer immunotherapyBiomaterials, 2009
- In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in MiceScience Translational Medicine, 2009
- Brain Tumor Immunotherapy with Type‐1 Polarizing StrategiesAnnals of the New York Academy of Sciences, 2009
- Specific Targeting of Brain Tumors with an Optical/Magnetic Resonance Imaging Nanoprobe across the Blood-Brain BarrierCancer Research, 2009
- Dynamic MRI Using Iron Oxide Nanoparticles to Assess Early Vascular Effects of Antiangiogenic versus Corticosteroid Treatment in a Glioma ModelJournal of Cerebral Blood Flow & Metabolism, 2009
- Infection-mimicking materials to program dendritic cells in situNature Materials, 2009
- Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomasJournal of Translational Medicine, 2007
- CD8+ T‐cell memory in tumor immunology and immunotherapyImmunological Reviews, 2006
- Fluorescent Nanoparticle Uptake for Brain Tumor VisualizationNeoplasia, 2006
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003